Funds will go toward the American Society of Clinical Oncologists Young Investigator Award
A Network of 19 Independent Practices Across 17 States
Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.
Dartmouth scientists found a therapeutic approach that should prevent the development of resistance to targeted anti-tumor drugs in gliomas
Funding supports search for new treatments for the deadliest form of cancer
CytoTest announces a significant expansion of its sales team.
QCDR Status Cements Organization's Dedication to Upholding Clinical Standards
Cancer DNA mutations can now be detected in the blood in femtogram concentrations (one femtogram = one thousand trillionth of a gram)
In this study of 5,000 women, more women who received Paclitaxel once a week were likely to be alive and free of breast cancer five years after being diagnosed compared to women who received Paclitaxel every three weeks OR women who received Docetaxel (either weekly or every three weeks).
Long-awaited Requirements Will Drive Adoption Rates in Key Markets According to Greystone Research Associates
Amber Kandur, of Highlands Oncology Group, Completed Certification Program in Healthcare Compliance
Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence.
Highlands Oncology Group Recognized With Corporate Sponsorship Award
Dr. Hershey Garner, of Highlands Oncology Group, Voted Best Oncologist in Northwest Arkansas By Readers' Poll
Jacques Corriveau joining as General Manager North America